• Join
  • Login
  • Contact

Search abstracts / presentations

New drug targeting and monitoring of bendamustine treatment in patients with chronic lymphocytic leukemia (cll)

  • In: Hospital Pharmacy Section Posters
  • At: New Orleans (USA) (2004)
  • Type: Poster
  • Poster code: HPS-P001
  • By: KOSTOVSKI, Aleksandar (Faculty of Pharmacy, Sofia, Pharmacology and Toxicology, Sofia, Bulgaria)
  • Co-author(s): Konstantinov (Faculty of Pharmacy, Sofia, SOFIA, Bulgaria)
    Alaikov (University Hospital St. Anna, Bulgaria)
    Karaivanova (Faculty of Pharmacy, Sofia, SOFIA, Bulgaria)
  • Abstract:


    CLL is characterized by a progressive accumulation of functionally incompetent long-lived CD5+ B-lymphocytes which are monoclonal in origin. Bendamustine is a benzimidazole derivative with two alkylating groups. Fludarabine is a fluorinated adenine derivative belongs to the group of antimetabolites. Erucylphospho-N, N,..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses